HER2 Negative Breast Cancer Overview

Save information for later
Sign Up

Learn About HER2 Negative Breast Cancer

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top HER2 Negative Breast Cancer Local Doctors?
General Surgery | Surgical Oncology
General Surgery | Surgical Oncology

Eastern Maine Medical Center

33 Whiting Hill Rd, 
Brewer, ME 
 (46.9 mi)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Kimberly Lieber is a General Surgeon and a Surgical Oncologist in Brewer, Maine. Dr. Lieber and is rated as an Advanced provider by MediFind in the treatment of HER2 Negative Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, Inflammatory Breast Cancer, and Lymphadenectomy. Dr. Lieber is currently accepting new patients.

Vascular Surgery
Vascular Surgery
60 High St, 
Lewiston, ME 
 (42.4 mi)
Languages Spoken:
English

Pamela Rietschel is a Vascular Surgeon in Lewiston, Maine. Dr. Rietschel and is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. Her top areas of expertise are BRCA Positive Breast Cancer, HER2 Negative Breast Cancer, and Lymphadenectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Nurse Practitioner
Nurse Practitioner

Central Maine Medical Center

300 Main St, 
Lewiston, ME 
 (42.4 mi)
Languages Spoken:
English
Accepting New Patients

Stacie Kunas is a Nurse Practitioner in Lewiston, Maine. Kunas and is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. Her top areas of expertise are HER2 Negative Breast Cancer and BRCA Positive Breast Cancer. Kunas is currently accepting new patients.

What are the Latest Advances for HER2 Negative Breast Cancer?
What are the latest HER2 Negative Breast Cancer Clinical Trials?
Neoadjuvant and Adjuvant Ribociclib and Endocrine Therapy for Clinically High-risk Estrogen Receptor-positive (ER+) and HER2-negative (HER2-) Breast Cancer

Summary: This is an open-label, multicenter international trial in men and women with primary operable HR+/HER2-, ki67≥20%, grade 2 or 3 and stage II breast cancer to evaluate safety and long-term efficacy of a non-chemo treatment in patients biologically responders to neoadjuvant ribociclib and letrozole. This study aims to evaluate whether chemotherapy could be avoided for initial high-risk clinicopathol...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase II Study of Ribociclib and Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer

Summary: This is an open label, multicenter, single arm phase II study to evaluate the efficacy and safety of ribociclib and ET in patients with locoregional recurrence of HR-positive, HER2-negative breast cancer.